FDA Inspection 1248218 — Daniel C. Tarquinio, DO
The FDA completed an inspection of Daniel C. Tarquinio, DO on Aug 23, 2024 in Norcross, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 23, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Norcross, GA (United States)
Additional Details
Clinical Investigator (CI)